BIOTECHNOLOGY INVESTMENTS
BIOTECHNOLOGY INVESTMENTS
Founded:
1986-01-01
Status:
Closed
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 1998-12-14 | OraPharma Inc. (acquired by JNJ) | Biotechnology Investments investment in Venture Round - OraPharma Inc. (acquired by JNJ) | 16 M USD |
| 1993-09-09 | GelTex Pharmaceuticals | Biotechnology Investments investment in Venture Round - GelTex Pharmaceuticals | 6.8 M USD |
| 1992-05-04 | NPS Pharmaceuticals | Biotechnology Investments investment in Seed Round - NPS Pharmaceuticals | 5 M USD |
| 1991-08-19 | Genta | Biotechnology Investments investment in Venture Round - Genta | 8.4 M USD |
| 1987-12-09 | Viagene Inc | Biotechnology Investments investment in Seed Round - Viagene Inc | 1000 K USD |
More informations about "Biotechnology Investments"
Industry Analysis Reports - BIO
The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... This report investigates recent …See details»
Biotechnology Innovation Organization - Wikipedia
BIO holds its annual international conference each year in the United States. This conference provides networking, business development and partnering activities that are essential to the biotechnology industry, in which developing products take considerable time and resources and regulatory risks are high. In 2021, BIO shifted its in-person meetings to virtual, due to restrictions and difficulties arising from the COVID-19 pandemic. See details»
New BIO Report Finds More Innovation & Investment Needed in …
Jan 25, 2024 Today, the Biotechnology Innovation Organization (BIO) released a new report, "The State of Innovation in Vaccines and Prophylactic Antibodies for Infectious Diseases," …See details»
What to know about BIO’s 7 Core Strategic Priorities
Oct 3, 2024 With the 118th Congress wrapping up in a few months, the Biotechnology Innovation Organization (BIO) continues its work to improve policy that impacts the biotechnology industry and to foster an ecosystem …See details»
BIO Investor Forum 2023 kicks off – here’s why …
Oct 17, 2023 The Biotechnology Innovation Organization (BIO) Investor Forum 2023 is taking place October 17-18, 2023, in San Francisco, California, bringing together biotech startups and drug development programs ready for …See details»
Beyond Borders: EY Biotechnology Report …
The 34th edition of our annual Beyond Borders biotech outlook report sees US and European biotechnology companies facing an imminent recovery in the operating environment. Companies …See details»
As biotech recovers, venture firms’ …
Jun 6, 2024 For one, venture investment appears to have stabilized at levels seen prior to a pandemic-era spike. Data presented by the Biotechnology Innovation Organization at …See details»
Ontario Investing $40 Million in Life Sciences Sector
Jun 5, 2024 We look forward to working together to attract new opportunities and investments into our province’s life sciences sector.” Minister Fedeli announced this investment at the Biotechnology Innovation Organization …See details»
Home - BIOTECanada
5 days ago Insights Magazine The latest issue of Insights magazine is now available. From the role of biomanufacturing in Canada, alongside the strategic roles of investment and …See details»
OBIO®
2025 OBIO® Investment Summit. Feb 5, 2025 – Feb 7, 2025. Feb 5, 2025 – Feb 7, 2025. More events NEWS. Featured. Dec 17, 2024. Zamplo App Aims to Transform Radiation Therapy …See details»
What are the biotech investment themes that will shape the …
Jun 10, 2022 The past three years have seen a boom in venture capital (VC) funding in the biotechnology sector. Our research shows that VC companies invested in 2,200 biotech start …See details»
Canada’s Biotechnology Sector Welcomes Federal Economic …
5 days ago Combined, the Economic Statement’s proposed measures will increase the availability of investment capital and enhance the ability of companies to effectively deploy that …See details»
Emerging Therapeutic Company Investment and Deal Trends - BIO
Emerging Therapeutic Company trends across five areas of investment and deal-making: venture capital, initial public offerings (IPOs), follow-on public offerings, licensing, and acquisitions. …See details»
Capital BioVentures | Ottawa’s Biotech Accelerator
Capital BioVentures also aims to support a select number of Ottawa life science companies with non-dilutive grant support and/or equity investment. Portfolio Companies NuvoBio is a peptide …See details»
Biotech | Life Sciences - McKinsey & Company
An early-stage oncology focused biotech was planning for public listing and we supported them in crafting the IPO equity story. We synthesized key value drivers by assessing portfolio and …See details»
Federal Budget Recognizes Strategic Importance of Canada’s …
Apr 19, 2021 BIOTECanada, the national biotechnology industry association representing the biotechnology research and development ecosystem in life sciences, agriculture, industrial and …See details»
VC funding trends in biotechnology | McKinsey - McKinsey
Dec 12, 2023 Amid a challenging public-market environment, venture capital (VC) funding has provided a much-needed lifeline to fuel biotech innovation. Despite also registering a decline …See details»
The Top 10 Private Equity Firms for Biotechnology | Leland
May 21, 2024 Casdin Capital is an investment firm that has carved out a niche for itself in the biotechnology sector through strategic investments in next-generation life sciences and …See details»
Biotech investment landscape: Strategies and forecasts for 2024
Apr 19, 2024 RTW Investments is a global multi-strategy investment firm focused on supporting innovative biotech and biopharma companies across the US, Europe, and China. To get an …See details»
5 oversight considerations for emerging biotech boards: PwC
3 days ago The biotechnology landscape is constantly evolving, with new scientific discoveries, regulatory changes, and market dynamics. ... Board members should consider supporting …See details»